169 related articles for article (PubMed ID: 36104270)
1. ASPSCR1-TFE3 fusion in a case of Xp11 translocation PEComa of the liver: are ASPSCR1-TFE3 fusion-bearing tumours Xp11 translocation PEComa or alveolar soft part sarcoma?
Chai J; Ma J; Liu Y; Zhao D; Yin Z; Wang Z; Fan L
Pathology; 2023 Apr; 55(3):416-419. PubMed ID: 36104270
[No Abstract] [Full Text] [Related]
2. Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions.
Martignoni G; Gobbo S; Camparo P; Brunelli M; Munari E; Segala D; Pea M; Bonetti F; Illei PB; Netto GJ; Ladanyi M; Chilosi M; Argani P
Mod Pathol; 2011 Oct; 24(10):1313-9. PubMed ID: 21602817
[TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.
Hodge JC; Pearce KE; Wang X; Wiktor AE; Oliveira AM; Greipp PT
Mod Pathol; 2014 Jan; 27(1):113-27. PubMed ID: 23828314
[TBL] [Abstract][Full Text] [Related]
4. PEComa-like Neoplasms Characterized by ASPSCR1-TFE3 Fusion: Another Face of TFE3-related Mesenchymal Neoplasia.
Argani P; Wobker SE; Gross JM; Matoso A; Fletcher CDM; Antonescu CR
Am J Surg Pathol; 2022 Aug; 46(8):1153-1159. PubMed ID: 35848761
[TBL] [Abstract][Full Text] [Related]
5. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.
Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
[TBL] [Abstract][Full Text] [Related]
6. PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma.
Zhao M; Huang Y; Yin X; Xu J; Sun Y; Wang J
Histopathology; 2024 Feb; 84(3):482-491. PubMed ID: 37936565
[TBL] [Abstract][Full Text] [Related]
7. Xp11 Translocation Renal Cell Carcinoma and the Mesenchymal Counterparts: An Evolving Concept with Novel Insights on Clinicopathologic Features, Prognosis, Treatment, and Classification.
Wang XT; Xia QY; Zhou XJ; Rao Q
Crit Rev Oncog; 2017; 22(5-6):481-497. PubMed ID: 29604926
[TBL] [Abstract][Full Text] [Related]
8. Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage.
Ellis CL; Eble JN; Subhawong AP; Martignoni G; Zhong M; Ladanyi M; Epstein JI; Netto GJ; Argani P
Mod Pathol; 2014 Jun; 27(6):875-86. PubMed ID: 24309327
[TBL] [Abstract][Full Text] [Related]
9. Alveolar Soft Part Sarcoma.
Jaber OI; Kirby PA
Arch Pathol Lab Med; 2015 Nov; 139(11):1459-62. PubMed ID: 26516944
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanotic Xp11 neoplasms exhibit a clinicopathologic spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification.
Wang XT; Fang R; Zhang RS; Ye SB; Li R; Wang X; Pan R; Liu C; Chen JY; Zhao M; Teng XD; Yu WJ; Li YJ; Wang FH; Zhang JG; Yang QC; Zhang YS; Lu ZF; Ma HH; Zhou XJ; Xia QY; Rao Q
J Pathol; 2020 Aug; 251(4):365-377. PubMed ID: 32418203
[TBL] [Abstract][Full Text] [Related]
11. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV
Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891
[TBL] [Abstract][Full Text] [Related]
12. Gene of the month: TFE 3.
Pinto K; Chetty R
J Clin Pathol; 2020 Nov; 73(11):691-694. PubMed ID: 32820043
[TBL] [Abstract][Full Text] [Related]
13. Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript.
Tsuji K; Ishikawa Y; Imamura T
Hum Pathol; 2012 Mar; 43(3):356-63. PubMed ID: 21835426
[TBL] [Abstract][Full Text] [Related]
14. Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics.
Schoolmeester JK; Carlson J; Keeney GL; Fritchie KJ; Oliva E; Young RH; Nucci MR
Am J Surg Pathol; 2017 May; 41(5):622-632. PubMed ID: 28009610
[TBL] [Abstract][Full Text] [Related]
15. Melanotic Xp11/TFE3 translocation perivascular epithelioid cell tumor of the kidney in an 11-year-old female.
Ma Y; Feng J; Tian F; Ding D; Zhao J
Pediatr Blood Cancer; 2023 Jan; 70(1):e29843. PubMed ID: 35695480
[No Abstract] [Full Text] [Related]
16. Lingual Alveolar Soft Part Sarcoma in a 1-Year-Old Infant: Youngest Reported Case With Characteristic ASPSCR1-TFE3 Fusion.
Ruffle A; Cameron M; Jonas N; Levine S; Mills C; Hook CE; Murray MJ
Pediatr Dev Pathol; 2019; 22(4):391-395. PubMed ID: 30744536
[TBL] [Abstract][Full Text] [Related]
17. Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas.
Aulmann S; Longerich T; Schirmacher P; Mechtersheimer G; Penzel R
Histopathology; 2007 Jun; 50(7):881-6. PubMed ID: 17543078
[TBL] [Abstract][Full Text] [Related]
18. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
[TBL] [Abstract][Full Text] [Related]
19. Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma.
Argani P; Aulmann S; Karanjawala Z; Fraser RB; Ladanyi M; Rodriguez MM
Am J Surg Pathol; 2009 Apr; 33(4):609-19. PubMed ID: 19065101
[TBL] [Abstract][Full Text] [Related]
20. Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein.
Kobos R; Nagai M; Tsuda M; Merl MY; Saito T; Laé M; Mo Q; Olshen A; Lianoglou S; Leslie C; Ostrovnaya I; Antczak C; Djaballah H; Ladanyi M
J Pathol; 2013 Apr; 229(5):743-754. PubMed ID: 23288701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
